Transphorm, Inc. Common Stock
TGAN
TGAN was delisted on the 20th of June, 2024.
38 hedge funds and large institutions have $183M invested in Transphorm, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 3 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more capital invested
Capital invested by funds: $138M → $183M (+$45.2M)
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
5% less funds holding
Funds holding: 40 → 38 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$1.41M |
| 2 |
State Street
Boston,
Massachusetts
|
+$175K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$169K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$163K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$90.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$308K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$252K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$126K |
| 4 |
Goldman Sachs
New York
|
-$89K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$59.6K |
TGAN Hedge Fund Activity: Q3 2022 in Review
38 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q3 2022, worth a combined $183M — up 33% from $138M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TGAN and 1 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 16 added.
The largest buyer was Worth Venture Partners, adding an estimated $1.41M. The largest seller was Vanguard Group, cutting an estimated $308K.
- 38 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q3 2022, down from 40 in Q2 2022.
- Funds reported $183M of Transphorm, Inc. Common Stock stock for Q3 2022, up 33% quarter-over-quarter.
- 1 fund opened new Transphorm, Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of -2 holders.
- The largest Transphorm, Inc. Common Stock buyer in Q3 2022 was Worth Venture Partners, an estimated $1.41M added.
- The largest Transphorm, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $308K sold.
Based on aggregated 13F filings for Q3 2022.